Article
Adrenomedullin as a potential biomarker involved in patients with hereditary hemorrhagic telangiectasia.
European journal of internal medicine - 1 Jun 2021
Iriarte A, Ochoa-Callejero L, García-Sanmartín J, Cerdà P, Garrido P, Narro-Íñiguez J, Mora-Luján J M, Jucglà A, Sánchez-Corral M A, Cruellas F, Gamundi E, Ribas J, Castellote J, Viñals F, Martínez A, Riera-Mestre A
Abstract excerpt
BACKGROUND: Adrenomedullin (AM) is a vasoactive peptide mostly secreted by endothelial cells with an important role in preserving endothelial integrity. The relationship between AM and hereditary hemorrhagic telangiectasia (HHT) is unknown. We aimed to compare the serum levels and tissue expression of AM between HHT patients and controls. METHODS: Serum AM levels were measured by radioimmunoassay and compared...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
